Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: A global phenomenon.
By: Tan R, Cvetkovski B, Kritikos V, Price D, Yan K, Smith P, Bosnic-Anticevich S.
Asthma Research and Practice 2017 Nov 21;3:8.
Summary: Patients with allergic rhinitis often trivialise their condition, self-manage inappropriately, and would benefit from healthcare intervention. This study aimed to identify the burden of allergic rhinitis in a community pharmacy and identify key opportunity for intervention. Pharmacy customers who purchased nasal treatment were approached with to do a questionnaire geared towards nasal symptoms. Of the 296 participants, 69.9% self-managed with OTC medications. Of those with allergic rhinitis symptoms, 44.3% had a doctor’s diagnosis. Nasal congestion (73.6%) was most commonly experienced and oral antihistamines were most commonly purchased (44.3%), indicating a pattern of sub-optimal management. A third of participants (36.5%) experienced moderate-severe symptoms persistently. Medication selection was mainly based on pharmacy customers’ perceptions of medication effectiveness (47.6%).